On April 26, the European Commission has filed a lawsuit against AstraZeneca Company that produces the vaccine against Covid-19 due to the non-fulfillment of terms of the contract on the supply of vaccines to the EU as Europa press reported citing EU Commission Spokesperson Stefan De Keersmaecker.
“The European Commission on Friday has started the trial against the AstraZeneca on the basis of the violations of the treaty on the previous procurement. Some terms of the contract were not observed and the company did not provide a reliable strategy for the provision of the timely distribution of the doses,” he stated.
De Keersmaecker added that the European Commission has filed a lawsuit on behalf of itself and on behalf of 27 countries-members of the EU.
According to the contract, AstraZeneca is obliged to supply 180 million doses of the vaccine to the EU in the second quarter of this year and 300 million doses from December until June.
However, the company reported in March that it can supply only one-third of the volume.
In January 2021, AstraZeneca stated it would cut deliveries of its Covid-19 vaccine to the EU by 60% in the first quarter of the year due to production problems. The EU Health Commissioner expressed "deep dissatisfaction" at the news. Officials have not confirmed publicly how big the shortfall will be, but an unnamed EU official said that deliveries would be reduced to 31m - a cut of 60% - in the first quarter of this year. The drug firm had been set to deliver about 80 million doses to the 27 nations by March.
At the same time, European Commission President Ursula von der Leyen at the World Economic Forum in Davos called on vaccine manufacturers that have signed contracts with the EU to fulfill their obligations. According to her, Europe has contributed billions of dollars to the development of drugs from SARS-CoV-2 "and now the companies must fulfill their obligations and supply vaccines." Von der Leyen also announced that Brussels intends to create a mechanism to control the export of vaccines outside the EU.